title: Evaluation and treatment of hip dysplasia in cerebral palsy.
abstract: Hip problems, including progressive subluxation, dislocation, and pain, are common in patients with cerebral palsy, particularly those who are nonambulatory with a large degree of spasticity. Clinical and radiographic screening facilitates early detection, and surgery is indicated to prevent progressive dysplasia. Although an early soft tissue release may prevent progressive subluxation in a subset of cases, bony reconstructive surgery is indicated for patients with established bony deformity. Salvage procedures are recommended to treat chronic pain caused by established subluxation or dislocation.
authors.affiliation: Division of Orthopaedic Surgery, Children's Hospital of Philadelphia, 2nd Floor Wood Building, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA. spiegeld@email.chop.edu
authors.forename: David A
authors.initials: DA
authors.lastname: Spiegel
authors.forename: John M
authors.initials: JM
authors.lastname: Flynn
mesh_terms: D000077:Acetabulum / Q000601:surgery; D001174:Arthrodesis; D001178:Arthroplasty; D001848:Bone Diseases, Developmental / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002547:Cerebral Palsy / Q000150:complications* / Q000503:physiopathology; D002648:Child; D018450:Disease Progression; D005269:Femur / Q000601:surgery; D006621:Hip Joint / Q000503:physiopathology; D006801:Humans; D009128:Muscle Spasticity; D009465:Neuromuscular Agents / Q000627:therapeutic use; D010027:Osteotomy; D010808:Physical Examination; D016059:Range of Motion, Articular
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A